Sriram D Rao1, Jonathan N Menachem2, Edo Y Birati1, Jeremy A Mazurek3,4. 1. Advanced Heart Failure/Transplantation Program, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. 2. Advanced Heart Failure and Cardiac Transplant Program, Advanced Congenital Cardiac Therapies, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. 3. Advanced Heart Failure/Transplantation Program, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. jeremy.mazurek@pennmedicine.upenn.edu. 4. Pulmonary Hypertension Program, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. jeremy.mazurek@pennmedicine.upenn.edu.
Abstract
PURPOSE OF REVIEW: In patients with heart failure with reduced ejection fraction, the presence of pulmonary hypertension (PH-LHD) has a significant impact on their prognosis. The purpose of this review is to explain the methods of diagnosing PH-LHD and then discuss the available therapeutic options. RECENT FINDINGS: We begin by examining the methods of assessment of PH-LHD-echocardiography, cardiopulmonary exercise testing, and right heart catheterization-with a particular focus on the importance of accurate measurement to ensure the proper determination of PH-LHD. We then focus primarily on management of PH-LHD, with an examination of trials of therapeutic options, use of mechanical circulatory support, and transplantation. This review highlights the complexities in diagnosis and management of PH-LHD. We outline a number of useful ways to maximize the yield of diagnostic testing, as well as give suggestions on the use of medical therapies, the role of both temporary mechanical support and left ventricular assist device, and finally the ways to best bridge these patients to transplantation.
PURPOSE OF REVIEW: In patients with heart failure with reduced ejection fraction, the presence of pulmonary hypertension (PH-LHD) has a significant impact on their prognosis. The purpose of this review is to explain the methods of diagnosing PH-LHD and then discuss the available therapeutic options. RECENT FINDINGS: We begin by examining the methods of assessment of PH-LHD-echocardiography, cardiopulmonary exercise testing, and right heart catheterization-with a particular focus on the importance of accurate measurement to ensure the proper determination of PH-LHD. We then focus primarily on management of PH-LHD, with an examination of trials of therapeutic options, use of mechanical circulatory support, and transplantation. This review highlights the complexities in diagnosis and management of PH-LHD. We outline a number of useful ways to maximize the yield of diagnostic testing, as well as give suggestions on the use of medical therapies, the role of both temporary mechanical support and left ventricular assist device, and finally the ways to best bridge these patients to transplantation.
Entities:
Keywords:
Heart failure; Post capillary; Pulmonary hypertension; Ventricular dysfunction, left; Ventricular dysfunction, right
Authors: Doan Hoa Do; Judith Therrien; Ariane Marelli; Giuseppe Martucci; Jonathan Afilalo; Igal A Sebag Journal: Echocardiography Date: 2010-12-22 Impact factor: 1.724
Authors: Marco Guazzi; Robert Naeije; Ross Arena; Ugo Corrà; Stefano Ghio; Paul Forfia; Andrea Rossi; Lawrence P Cahalin; Francesco Bandera; Pierluigi Temporelli Journal: Chest Date: 2015-07 Impact factor: 9.410
Authors: Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch Journal: J Am Coll Cardiol Date: 2013-12-24 Impact factor: 24.094
Authors: Jeffrey S Arkles; Alexander R Opotowsky; Jason Ojeda; Frances Rogers; Tong Liu; Vikram Prassana; Lucas Marzec; Harold I Palevsky; Victor A Ferrari; Paul R Forfia Journal: Am J Respir Crit Care Med Date: 2010-08-13 Impact factor: 21.405